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Protein phosphorylation plays an important role in pheromone-induced differentiation processes of haploid
yeast cells. Among the components necessary for signal transduction are the STE7 and STEll kinases and
either one of the redundant FUS3 and KSS1 kinases. FUS3 and presumably KSS1 are phosphorylated and
activated during pheromone induction by a STE7-dependent mechanism. Pheromone also induces the
accumulation of STE7 in a hyperphosphorylated form. This modification of STE7 requires the STEll kinase,
which is proposed to act before STE7 during signal transmission. Surprisingly, STE7 hyperphosphorylation
also requires a functional FUS3 (or KSS1) kinase. Using in vitro assays for FUS3 phosphorylation, we show that
pheromone activates STE7 even in the absence of FUS3 and KSS1. Therefore, STE7 activation must precede
modification of FUS3 (and KSS1). These findings suggest that STE7 hyperphosphorylation is a consequence of
its activation but not the determining event.
The yeast Saccharomyces cerevisiae can be induced to
arrest growth at the G1 phase of the cell cycle and to follow
a differentiation program that results in mating between a
and a haploid cells. The interaction of extracellular peptide
pheromones, a-factor and a-factor, with their respective cell
surface receptors initiates the process (for review, see ref-
erences 8 and 23). A heterotrimeric G protein then trans-
duces the signal to cytoplasmic components of the signal
pathway (for a review, see reference 1). The intracellular
pathway transmits the signal to the nucleus, where it causes
transcription to be induced for a variety of genes whose
products execute the events of mating (for a review, see
reference 41). Additionally, the pheromone-induced signal
inhibits progression of the cell cycle at the G1 phase by
regulating the activity of G1-specific cyclins (for a review,
see reference 31).
Many genes that specify components of the pathway have
been identified, yet much remains to be learned about the
events of signal transmission subsequent to G-protein acti-
vation. For example, no studies have yet identified the
effector molecule that receives the signal from the G protein.
Additionally, we do not know the chemical nature of the
signal or how the pathway transmits it to the ultimate targets
of transcriptional and cell cycle regulation. Four genes
(STE7, STE11, FUS3, and KSS1) encode proteins with
homology to protein kinases (7, 12, 36, 44). Genetic analyses
established that each of these products functions in signal
transmission after the G protein (11, 28). Therefore, protein
phosphorylation is expected to play a key role in signal
transmission from the G protein to the targets responsible for
pheromone responses.
Evidence that protein phosphorylation is directly involved
in transmitting the pheromone-induced signal comes from
recent studies on the FUS3 kinase (15). FUS3 is a member of
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the conserved family of MAP kinases (ERKs) (for a review,
see reference 32). Similar to mammalian MAP kinases,
pheromone induces phosphorylation at two amino acids in
FUS3, T-180 and Y-182. Substitution mutations introduced
at either of these positions cause complete loss of FUS3
function in vivo. Therefore, the pheromone-induced phos-
phorylation activates the FUS3 kinase. Interestingly, a cat-
alytically inactive substitution mutant, FUS3-R42 (in mutant
names, the superscript numbers indicate amino acid posi-
tions), is still phosphorylated on both T-180 and Y-182. This
result excludes the possibility that the phosphorylations are
autocatalytic. By contrast, FUS3 phosphorylation requires
function of both the STEll and STE7 kinases (15).
We studied the STE7 protein to learn whether it is
involved in pheromone-induced protein phosphorylation and
what its relationship is to the other kinases that function in
the same signal pathway. We and others have reported that
STE7 becomes hyperphosphorylated in response to phero-
mone or in the presence of activated forms of the STEll
kinase, even in the absence of pheromone induction (2, 42).
We show here that this hyperphosphorylation requires the
presence of signal transmission components, including the
STEll kinase and either the FUS3 or KSS1 kinase, that are
redundant for this step in signal transmission. Given that
FUS3 activity requires STE7-dependent phosphorylation,
the dependence of STE7 hyperphosphorylation on the FUS3
kinase is a paradox. Experiments to resolve this dilemma
showed that pheromone activates STE7 function in the
absence of FUS3 and KSS1, a condition in which STE7 is
not hyperphosphorylated. These findings suggest that STE7
hyperphosphorylation is a consequence of its activation but
not the determining event.
MATERIALS AND METHODS
Plasmid constructions. We expressed STE7 from the CYCI
promoter for its overproduction in S. cerevisiae. The STE7
2069
Vol. 13, No. 4





H R RG R C H
ATGACCGGATCCATGGTTCAA
MT G S MV a
myc
GAGCAAAAGCTCATTTCTGAAGAGGACTTGAAT













FIG. 1. Representation of the STE7 locus and STE7 plasmids.
(A) The 2.1-kb HindIII fragment from pSTE7.4 is shown (44). The
open box delimits the STE7 protein coding sequence. Bars indicate
fragments (a) and (b) used to manipulate STE7 as described in the
text. The locations of selected restriction sites are shown. The insert
at the 5' boundary of the STE7 coding region shows the alteration in
DNA and amino acid sequence resulting from the fusion with CYCI
sequences in pNC226, pNC250, pNC267, pNC279, and pNC318.
The arrow shows the precise junction of CYCl and STE7 sequences.
The insert at the 3' boundary of the STE7 coding region shows the
DNA and amino acid sequence of the STE7-Myc epitope fusion
(STE7M) in pNC267 and pNC318. (B) The 2,um-based plasmid
pNC226 (12.9 kb) allows expression of a STE7-13-galactosidase
fusion protein under control of the CYCI promoter and translation
initiation sequences. The 2,um-based plasmid pNC250 (10.0 kb) and
the centromeric plasmid pNC279 (8.4 kb) allow expression of STE7
under control of the above-specified CYCI sequences. Plasmids
pNC267 (10.9 kb) and pNC318 (8.4 kb) express the STE7M protein
that is a STE7-Myc epitope fusion. The ampicillin resistance gene
(apr), M13 origin of replication (M13), and yeast-derived compo-
nents are specified. Only those restriction sites used for plasmid
constructions are indicated. Abbreviations for restriction sites: B,
BamHI; G, BglII; C, ClaI; R, EcoRV; H, HindIII; N, Ncol; P,
PvuII; S, SalIl.
expression plasmid pNC226 has an in-frame fusion of STE7
with the complete lacZ gene under control of the CYCl
promoter and translation start sequences. To construct this
fusion, we introduced NcoI sites at the translation start and
stop codons of STE7 by oligonucleotide-directed mutagene-
sis. The template DNA for mutagenesis reactions was M13-
STE7.1, which is an M13mpl8 clone carrying the 2.1-kb
HindIII fragment of STE7 from pSTE7.4 (Fig. 1A). The two
oligonucleotide primers for mutagenesis were 5'-TC'TTTCG
TTGAACCATGGCCAACAACCAAT and 5'-ATCGCATG
CATTCAGGATCCCCATGGGTTGATCTTT (homologous
to STE7 nucleotide positions 346 to 375 and 1891 to 1918,
respectively [44]). Mutagenesis procedures were as previ-
ously described (36). The 1.6-kb Ncol-Ncol fragment (a in
Fig. 1A) from the resulting mutant clone was end repaired
and subcloned into the BamHI site (end repaired) of the
pUC118 polylinker (46). Ligation of the repaired BamHI and
NcoI ends preserves the BamHI and NcoI sites at both
junctions. We subcloned the BamHI fragment (a) into the
unique BamHI site of pLG669-Z to give pNC226 (Fig. 1B)
(16). These manipulations alter the N terminus of the STE7
protein so that there are an additional four amino acids from
CYCl and a substitution of Val for Phe at the normal STE7
amino acid position 2 (Fig. 1A).
Plasmid pNC250 is a high-copy-number plasmid for ex-
pression of STE7 from the CYCl promoter (Fig. 1B). The
lacZ sequences from pNC226 were deleted and replaced by
the STE7 translation stop and transcription termination
sequences. To do this, we inserted the 1.2-kb BglII-HindIII
(end-repaired) fragment (b in Fig. 1A) from pSTE7.4 into
BglII- and PvuIl-digested pNC226 (Fig. 1). Plasmid pNC279
is a centromeric plasmid for expression of STE7 from the
CYCl promoter (Fig. 1B). We constructed pNC279 by
cloning the 1.6-kb SalI-BglII fragment from pNC250 and the
1.2-kb BglII-HindIII fragment (b) from pSTE7.4 into Sall-
and HindIII-digested pNC161 (35).
The Myc epitope tag was fused to STE7 at its C terminus
by site-directed mutagenesis (Fig. 1A). Single-stranded
DNA from M13-STE7.1 was the template for oligonucleoti-
de-primed DNA synthesis as described previously (36). The
oligonucleotide was 5'-CGCATGCATTCAATTCAAGTCC
TCTTCAGAAATGAGCTTTTGCTCATGGGTTGATCT.
The underlined sequences encode the tag, while flanking
sequences are homologous to STE7 nucleotide positions
1893 to 1916 (27, 44). The BglII-HindIII (end-repaired)
fragment from M13-STE7M replicative-form DNA was
cloned into BglII-PvuII-digested pNC226 as before to give
plasmid pNC267 (Fig. 1B). We constructed pNC318 by
replacing the STE7 BglII-HindIII fragment in pNC279 with
the corresponding fragment from M13-STE7M (Fig. 1B).
The Myc epitope tag was also fused to FUS3 at its C
terminus by site-directed mutagenesis. To obtain single-
stranded template DNA, the 1.2-kb EcoRI-BamHI fragment
from pGA1840 that contains the FUS3 coding sequence was
subcloned into M13mpl9 (15). The mutagenic oligonucle-
otide was 5'-AACGAAATA T'AGTGAGCAAAAAGCTCA
ITTCTGAAGAGGACTlGAAITAACCATCATTATCA.
The underlined sequences encode the tag and a stop codon,
while flanking sequences are homologous to FUS3 nucle-
otide positions 1309 to 1323 and 1327 to 1338 (12, 27).
Plasmid pGA1903 expresses FUS3M in S. cerevisiae under
control of the constitutive TPIJ promoter. It was con-
structed by replacing the EcoRI-BamHI fragment from
pGA1840 with the EcoRI-BamHI fragment from the modi-
fied M13 clone. Plasmid pGA1905 for constitutive expres-
sion of the FUS3 catalytic mutant protein (FUS3M-R42) in S.
cerevisiae was constructed by using the internal XhoI-
BamHI fragment from pGA1903 to replace the correspond-
ing fragment from pGA1892 (15). Plasmid pGA1944 for
constitutive expression of the phosphorylation site mutant
(FUS3M-R42A'80F182) was constructed by using the SacII-
XhoI from pGA1984 to replace the corresponding fragment
from pGA1905 (15).
Plasmid pNC111 carries the ste7-A3 allele used for gene
replacement. To construct pNC111, we first inserted the
5.2-kb SacI fragment from pSTE7.4 into the Sacl site of
pUC118-1 (44). pUC118-1 is a pUC118 derivative that is
missing the HindIII site in the polylinker (46). Two adjacent
HindIII fragments were deleted to create the ste7-A3 allele.
The deleted segment encompasses 3.1 kb that includes the
A.
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TABLE 1. Yeast strains
Strain Genotype Source orreference
E929-6C-0 MATa cycl CYC7-H2 canl leu2-3,112 trpl -Al ura3-52 5
E929-6C-1 MATa cycl CYC7-H2 canl leu2-3,112 trpl-Al ura3-52 ste7-A3::LEU2 5
E929-6C-6 MATa cycl CYC7-H2 canl leu2-3,112 trpl -Al ura3-52 stel2A::LEU2 14
E929-6C-10 MATa cycl CYC7-H2 canl leu2-3,112 trpl-Al ura3-52 ste7-A3 This work
E929-6C-14 MATa cycl CYC7-H2 canl leu2-3,112 trpl -Al ura3-52 ste4A::LEU2 This work
E929-6C-16 MATa cycl CYC7-H2 canl leu2-3,112 trpl -Al ura3-52 FUSJ-lacZ::URA3 39
E929-6C-18 MATa cycl CYC7-H2 canl leu2-3,112 trpl-Al ura3-52 FUSJ-lacZ::URA3 ste7-A3 This work
E929-6C-20 MATa cycl CYC7-H2 canl leu2-3,112 trpl-Al ura3-52 stell-A6 30
E929-6C-22 MATa cycl CYC7-H2 canl leu2-3,112 trpl-Al ura3-52 barl::LEU2 This work
E929-6C-30 MATa cycl CYC7-H2 canl leu2-3,112 trpl -Al ura3-52 fus3A6 LEU2 This work
E929-6C-34 MATa cycl CYC7-H2 canl leu2-3,112 trpl-Al ura3-52 ste5::LEU2 This work
E929-6C-35 MATa cycl CYC7-H2 canl leu2-3,112 trpl-Al ura3-52 barl::LEU2 ste7-A3 This work
E929-6C-48 MATa cycl CYC7-H2 canl leu2-3,112 trpl-Al ura3-53 ksslA::URA3 This work
E929-6C-49 MATa cycl CYC7-H2 canl leu2-3,112 trpl-Al ura3-52farlA::HISG This work
E929-6C-50 AM Ta cycl CYC7-H2 canl leu2-3,112 trpl-Al ura3-52 fus3A6::LEU2 ksslA::URA3 This work
E929-6C-53 MATa cycl CYC7-H2 canl leu2-3,112 trpl-Al ura3-52 FUS1-lacZ::LEU2 This work
E929-6C-54 MATa cycl CYC7-H2 canl leu2-3,112 trpl-Al ura3-52 FUSJ-lacZ::LEU2 ste7-A3 This work
KZ8-5C AM Ta cycl-l CYC7 his4 ural K. Zaret
KZ8-1D MATax cycl-l CYC7 his4 ural K. Zaret
D887-6D AL4Ta CYCI CYC7 canl ilv3 ura3 maklO F. Sherman
K2314 MATa HMLa HMRa canl-100 leu2 trpl ura3 ho::lacZ barl::HISGffus3A::LEU2 kssl::URA3 16
SY2172 AM Tat STEll-1 canl leu2 ura3 trpl his3A200::ura3pep4A::URA3 ste7A3::LEU2 FUSI::HIS3 42
entire STE7 coding region and a portion of a flanking
transcription unit. Plasmid pNC296 carries the FUSJ-lacZ
reporter gene for integration at the LEU2 locus. It is identi-
cal to the previously described plasmid pGA1716 except that
the LEU2 gene replaces the URA3 gene as the selectable
marker (36).
We performed all plasmid constructions and DNA manip-
ulations according to standard procedures. We purchased
enzymes from U.S. Biochemicals, New England Biolabs,
and Bethesda Research Laboratories.
Yeast genetic procedures and strain constructions. Unless
otherwise specified, we used standard media and genetic
procedures (39). Yeast strains were transformed by the
procedure of Ito et al. (18). For the construction of strains
with various deletions of pheromone response pathway
components (see below), we used the gene replacement
method of Rothstein (37). Plasmids p4-121 (ste4A::LEU2 [V.
MacKay, Zymogenetics, Seattle, Wash.]), pEE98 (fus3-A6::
LEU2 [12]), pJM-41 (steS::LEU2 [J. Mermoud and G. Am-
merer]), pGA1845 (farlA::HISG [G. Ammerer]), pBC65
(ksslA::URA3 [7]), pNC111 (ste7-A3), and pVZ77 (barl,A::
LEU2 [V. MacKay, Zymogenetics]) were the sources of
fragments for indicated gene replacements (Table 1). The
FUS1-lacZ::URA3 and FUS1-lacZ: :LEU2 strains were con-
structed by integration of pGA1716 (36) and pNC296, re-
spectively, at the corresponding URA3 or LEU2 locus. All
gene replacements and integrations were confirmed by
Southern blot analysis.
Pheromone induction and response assays. The a-factor
used for all pheromone inductions was synthesized in the
UNCCH-NIEHS Protein Chemistry Laboratory. We added
a-factor to exponentially growing cultures at a density of 5 x
106 cells per ml in medium as specified. The final concentra-
tion of cx-factor was 2.5 ,uM for BAR1+ strains or 50 nM for
barl strains. The G1 arrest phenotype of unbudded cells was
routinely monitored to verify pheromone response. For
these assays, we removed an aliquot of the culture at
appropriate intervals and added an equal volume of 36%
formaldehyde solution to fix the cells. The numbers of
budded and unbudded cells in the fixed cell suspension were
counted with a microscope and a hemacytometer grid. At
least 200 individual cells were scored for each sample. FUSI
expression is a standard reference for pheromone-induced
transcription (25, 45). To monitor expression, we measured
3-galactosidase activity expressed from the FUS1-lacZ re-
porter gene. Assays for 3-galactosidase activity were done
as previously described (36). We scored mating competence
by the patch test (40). The a and a tester strains were
KZ8-5C and KZ8-1D, respectively (Table 1). Quantitative
mating assays were performed with tester strain D887-6D
(Table 1) essentially as described by Clark and Sprague (4).
STE7 immunological analyses. We grew strains on the
appropriate selective medium for maintenance of plasmids.
The medium contained 1% sucrose as the carbon source for
all cultures requiring STE7 expression from the CYCI pro-
moter (pNC250, pNC267, pNC279, or pNC318). Cultures
were grown to a density of 5 x 106 to 1 x 107 cells per ml.
Unless otherwise specified, we prepared protein extracts
according to the procedure described by Company et al. (5).
Where trichloroacetic acid (TCA)-sodium dodecyl sulfate
(SDS) extracts are specified, they were prepared by the 5%
TCA fixation and 1% SDS-glass bead lysis procedure de-
scribed by Moll et al. (26).
We performed STE7M immunoprecipitations by using 100
,g of extract under conditions described for STEllM (36).
Proteins for immunoblot analyses were fractionated by SDS-
polyacrylamide gel electrophoresis on 7.5% polyacrylamide
gels (21). We used the Mycl-9E10 monoclonal antibody (2
,ug/ml) to detect the STE7M and STE7M-R220 proteins and
affinity-purified anti-STE7 antibodies (0.7 ,ug/ml) to detect
STE7. The anti-STE7 antiserum was a generous gift from D.
T. Chaleff. The Promega Protoblot immunoblot system with
the respective goat anti-mouse immunoglobulin G or goat
anti-rabbit immunoglobulin G conjugated to alkaline phos-
phatase (0.1 ,ug/ml) was to detect the primary antibody by
colorimetric methods.
Dephosphorylation of whole cell protein extracts. Sixty
micrograms of protein extract from strain E929-6C-10/
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TABLE 2. Effects of STE7 and STE7-R220 overproduction on mating and pheromone-induced transcription
Mating FUSJ-lacZ expression
Strain Plasmid Relevant genotype Mating (3-galactosidase activity')
Patch test' Relative efficienCyb Uninduced Induced
E929-6C-18 pNC161 ste7A - <2 x 10-7 4 6
pNC318 ste7A [CYCJ-STE7Ml + 0.97 100 2,700
pNC318-R220 ste7A [CYCI-ste7M-R220] - <2 x 10-7 7 6
E929-6C-16 pNC161 STE7 + ND 80 4,100
pNC318 STE7 [CYC1-STE7MJ + ND 200 5,800
pNC318-R220 STE7 [CYCI-ste7M-R220] + ND 60 4,400
E929-6C-53 YEp24 STE7 + 1.00 100 7,800
pNC250 STE7 [CYCI-STE7] + 0.87 50 5,100
pNC250-R220 STE7 [CYCI-ste7-R220] -/+ 0.08 30 1,200
a Scored as strong (+, confluent patch), weak (-/+, spotty growth), or sterile (-, no growth) according to the growth of diploid cells on selective medium after
mating with tester strain KZ8-1D.
b Numbers presented are the mating efficiency for each strain relative to the STE7 control strain (E929-6C-53/YEp24). Absolute mating efficiencies were
determined as described in Materials and Methods, using tester strain D887-6D. ND, not determined.
c Units of 1-galactosidase activity are milliunits of optical density at 420 nm per minute per milligram of protein.
pNC250 wvas incubated with 20 U of calf intestine alkaline
phosphatase (Boehringer Mannheim) in phosphatase buffer
(50 mM Tris-HCl [pH 8.0], 1 mM MgCI2, 0.1 mM ZnCl2) for
15 min at 37°C. We carried out a parallel reaction with 60 ,ug
of extract in the same buffer but with the addition of two
phosphatase inhibitors, 70 mM molybdic acid and 16 mM
PP1. For reference, we incubated 60 ,ug of extract for 15 min
at 37°C in phosphatase buffer without addition of phos-
phatase.
In vivo labeling. For analysis of STE7, we grew cultures of
yeast strain E929-6C-35/pNC267 to 5 x 10 cells per ml in
synthetic medium lacking uracil (-Ura medium). For label-
ing with 32Pi, we harvested 50 ml of culture and suspended
the cell pellet in 15 ml of phosphate-free medium. Cells were
incubated in this medium at 30°C for 4 to 5 h to deplete
endogenous phosphate stores before the addition of 1 mCi of
32pO4 (ICN) (38). The culture was immediately divided, and
ax-factor (50 nM, final concentration) was added to one
portion. Cells were harvested after 1 h of incubation at 30°C
for preparation of protein extracts (5, 26). Immunoprecipi-
tated STE7 protein from the pheromone-induced extracts
was recovered from dried gels, and phosphoamino acid
analysis was performed by the method of Cooper et al. (6).
In vivo 32p labeling of FUS3 and immunoprecipitation
procedures were done exactly as described previously (15).
For labeling STE7 with [35S]methionine, we harvested 200
ml of culture (E929-6C-35/pNC267). The cells were sus-
pended in 20 ml of -Ura medium with 1 mCi of [35S]methio-
nine (ICN) and incubated for 1 h at 30°C. The cells were
harvested and suspended in 200 ml of -Ura medium in the
presence of 20 ,ug of cycloheximide per ml to stop further
protein synthesis. After 10 min, the culture was divided into
two portions, and a-factor was added to one of them as
before. Cells were harvested after 1.5 h of incubation at 30'C
for preparation of protein extracts (5).
In vitro FUS3 phosphorylation assays. Extracts for the
FUS3 phosphorylation assays were prepared from 50-ml
cultures of strains E929-6C-35/pGA1905, E929-6C-35/
pGA1944, K2314/pGA1905, K2314/pNC318, and K2314/
pNC318-R220 essentially according to previously described
procedures (43). Strains were grown on selective medium to
an optical density at 600 nm of 0.8 to 1.2. Pheromone-
induced cultures were incubated with synthetic a-factor for
30 min before cells were harvested.
Phosphorylation assays were performed directly on pro-
tein A-Sepharose-adsorbed immune complexes. The anti-
body reactions took place on ice for 1 h in a 30-,ul volume
with 3 ,ug of Mycl-9E10 antibody and 180 ,ug of extract.
Where mixing experiments are indicated, 90 ,g of initiator
extract and 90 ,ug of acceptor extracts were mixed and
incubated at 30°C for 5 min prior to addition of antibody. The
antibody-antigen complexes were incubated with protein
A-Sepharose beads (10 ,ul, packed volume) at 4°C for 1 h on
a wheel for constant mixing. The adsorbed complexes were
washed four times with buffer A (50 mM Tris-HCI [pH 7.5],
150 mM NaCl, 15 mM MgCl2, 1% Nonidet P-40, 0.1 mM
orthovanadate, 15 mMp-4-nitrophenylphosphate) and twice
with buffer B (25 mM morpholine propanesulfonic acid
[MOPS; pH 7.2], 0.1 mM orthovanadate, 15 mM p-4-nitro-
phenylphosphate). After addition of 6 ,ul of kinase assay
buffer (25 mM MOPS [pH 7.2], 15 mM MgCl2, 5 mM EGTA,
1 mM dithiothreitol, 0.1 mM orthovanadate, 15 mM p-4-
nitrophenylphosphate, 1 mM phenylmethylsulfonyl fluoride,
40 ,g of aprotinin per ml, 20 ,ug of leupeptin_per ml) and 10
pl of ATP buffer (25 mM MOPS, 3 ,uCi of [_y- P]ATP [6,000
Ci/mmol]) to the washed complexes, the phosphorylation
reactions were carried out at 30°C for 5 min. Reactions were
stopped by the addition of 40 ,ll of SDS-polyacrylamide gel
electrophoresis (PAGE) sample buffer (21) and boiling for 3
min. In vivo labeling of FUS3 with 32Pi and immunoprecip-
itation procedures were carried out as described previously
(15).
RESULTS
STE7 overproduction. With the objective of making bio-
chemical and immunological analyses feasible, we designed
and tested the functions of different constructions for over-
production of STE7 and a Myc epitope fusion protein,
STE7M (Fig. 1). The STE7M protein is fully functional, as
judged by its ability to complement the mating, transcrip-
tional induction, and G1 arrest defects characteristic of a
complete deletion of the STE7 gene (ste7A) (Table 2, E929-
6C-18/pNC318; Fig. 2C). It is noteworthy that there are no
deleterious effects from overexpression of STE7. Addition-
ally, we find that cells overproducing a functional STE7
(pNC318 or pNC250) show the same G1 arrest and transcrip-
tional responses to pheromone as do cells that express STE7
from its genomic location (Fig. 2A and C; Table 2). There-
fore, overproduction of STE7 is not sufficient to activate
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FIG. 2. Effects of STE7 and STE7-R2" overproduction on phero-
mone-induced G, arrest. The G1 arrest response was measured by the
percentage of unbudded cells in the culture at indicated times during
pheromone induction. The plots compare strains that overproduce the
functional STE7 or the inactive STE7-R'0 protein from the corre-
sponding high-copy-number plasmids (pNC250 [-] and pNC250-R220
[E]) or low-copy-number plasmids (pNC318 [A] and pNC318-R220
[A]). Strains that do not overproduce STE7 (YEp24 [x]) were included
for reference. (A and B) Comparison in strains with a functional copy
of STE7 at the genomic locus; (C and D) comparison in strains with a
complete deletion of the chromosomal STE7.
pathway responses in the absence of pheromone. This is in
contrast to what has been observed for the overproduction
of the GP subunit (STE4) and the STE12 transcription factor
(10, 47). This difference in behavior suggests that the STE7
protein may be present in a nonfunctional form until acti-
vated by the pheromone-induced signal. Alternatively, the
signal transduction pathway might be branched so that other
steps in signal transduction remain limiting.
A substitution mutation in the putative STE7 kinase domain
abolishes in vivo activity. The predicted amino acid sequence
of STE7 suggests that it is a member of the protein kinase
family (44). We wished to determine whether its predicted
function as a kinase would be required for both the G1 arrest
and transcriptional controls that are a prerequisite for mat-
ing. To do this, we examined the phenotype associated with
expression of the STE7-R220 protein, which has a substitu-
tion of arginine for lysine at STE7 position 220 (44a). This
position corresponds to the conserved lysine in the catalytic
domain that is required for activity of known protein kinases
(17, 19).
To evaluate STE7-R220 function, a ste7A yeast strain was
transformed with plasmids that either do not express STE7
(pNC161 and YEp24) or overproduce the functional STE7
(pNC318 and pNC250) or STE7-R220 (pNC318-R220 and
pNC250-R220) protein. Those strains that do not produce
STE7 or that produce the STE7-R220 protein are completely
mating defective (Table 2, E929-6C-18 pNC161 and pNC318-
R220). This result is contrary to another report that the
STE7-R220 mutant might have residual kinase activity or
have a secondary function in mating response such as
complex formation with another pathway component (2).
Because in that study the STE7-R220 mutant was analyzed in
a host strain with a disruption allele and not a deletion,
another explanation is more probable. The low frequency of
mating-competent cells was most likely due to reversion of
the ste7-R220 mutation by gene conversion with homologous
STE7 sequences in the genome.
As expected from the results of mating tests, the STE7-
R220 substitution is also completely defective in supporting
the G, arrest and transcriptional responses to pheromone
(Fig. 2D and Table 2). We conclude that the substitution
mutation is completely nonfunctional because even under
conditions in which STE7-R220 is overproduced, pheromone
responses are identical to what is observed in the complete
absence of STE7. (Compare E929-6C-18 pNC161 and
pNC318-R220 in Table 2 and Fig. 2D). Because a single
amino acid substitution that is known to abolish kinase
activity is responsible for these defects, the implication is
that STE7 kinase activity is crucial for its in vivo functions.
We also investigated the possibility that overexpression of
the STE7-R220 protein interferes with pheromone responses.
Strains with a normal STE7 gene at the chromosomal locus
were transformed with STE7-R220 and control plasmids as
before. When STE7-R220 was overexpressed from the CYCl
promoter but on a low-copy-number plasmid (pNC318-
R220), there was no interference with pheromone-induced
functions, as measured by quantitative mating, FUSJ-lacZ
expression, or G1 arrest (Table 2, E929-6C-16 pNC161 and
pNC318-R220; Fig. 2B). The situation was different when
STE7-R220 was overexpressed on a high-copy-number plas-
mid (pNC250-R220). Cells were defective in pheromone-
induced G, arrest, transcriptional activation, and overall
mating ability (Table 2, E929-6C-53 YEp24 and pNC250-
R220; Fig. 2B). Therefore, STE7-R220 has an inhibitory
effect on signal transduction only when it is highly overpro-
duced.
Immunological detection of STE7. We tested the specificity
and detection limits of rabbit anti-STE7 serum and the Myc
epitope-specific monoclonal antibody Mycl-9E10 (14, 27).
To do this, we examined immunoblots of extracts from
strains that either do not produce STE7 or produce different
amounts of STE7 (or STE7M). A strain with a complete
deletion of the chromosomal STE7 gene provided extract
that lacks STE7 protein. Yeast strains with STE7-expressing
plasmids provided extracts with different amounts of STE7
protein (Fig. 1, pSTE7.4, pNC279, pNC250, and pNC267).
The anti-STE7 polyclonal antibody or the Mycl-9E10
antibody detected the STE7 or STE7M polypeptide, respec-
tively, only with extracts having overproduced amounts of
STE7. A weak but detectable signal was observed with
extracts in which STE7 was expressed from its own pro-
moter but on a high-copy-number plasmid (Fig. 3A, lane 3).
The intensity of STE7-specific signals was substantially
increased with extracts in which STE7 was expressed from
the CYCl promoter on either a low- or high-copy-number
plasmid (Fig. 3A, lanes 4 and 5; Fig. 3B, lane 2). With either
antibody, we observed multiple signals corresponding to
polypeptides with molecular sizes of between 58 and 67 kDa.
We conclude that these signals are due to specific reaction of
the antibodies with multiple STE7 isoforms. First, we de-
tected no strong cross-reacting species in the control ex-
VOL. 13, 1993
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FIG. 3. Electrophoretically distinct STE7 species. (A) Immuno-
blot using anti-STE7 polyclonal antibodies to detect STE7 from
protein extracts (50 ,ug) of different strains. Lanes: 1, E929-6C-1 (no
STE7); 2, E929-6C-0 (chromosomal STE7); 3, E929-6C-1/pSTE7.4
(high-copy-number plasmid STE7); 4, E929-6C-1/pNC279 (low-
copy-number plasmid CYCl-STE7); 5, E929-6C-1/pNC250 (high-
copy-number plasmid CYCI-STE7). Sizes of the arrows above lanes
3 to 5 indicate the relative overproduction of STE7. (B) Immunoblot
using the anti-Myc monoclonal antibody Mycl-9E10 to detect
STE7M from protein extracts (50 pg) of different strains. Lanes: 1,
E929-6C-1 (no STE7M); 2, E929-6C-1/pNC267 (high-copy-number
plasmid CYC1-STE7M). Molecular size standards (kilodaltons) are
indicated at the left.
tracts with the anti-STE7 serum or the Mycl-9E10 mono-
clonal antibody (Fig. 3A, lanes 1 and 2; Fig. 4B, lane 1).
Second, the signal corresponding to the fastest-mobility
form is close to the 57-kDa size expected from the predicted
STE7 protein sequence. Because the other isoforms have
slower mobilities, it is unlikely that the multiple signals are
due to proteolytic breakdown of STE7 in the extracts.
Pheromone induction causes phosphorylation of preexisting
STE7. One common cause for altered mobility of proteins in
SDS-PAGE is a difference in phosphorylation state. There-
fore, we examined the effect that phosphatase treatment of
protein extracts would have on the electrophoretic profile of
STE7 on immunoblots. The phosphatase treatment depleted
the slower-migrating forms of STE7, and only the fastest-
migrating form remained (Fig. 4A, lane 3). The slower-
migrating forms persisted when phosphatase was added in
the presence of phosphatase-specific inhibitors (Fig. 4A,
lane 4).
To show directly that STE7 is a phosphoprotein, we
labeled a culture of cells that overproduce the STE7M
protein with 32pi. The STE7M protein was immunoprecipi-
tated from the labeled extracts with the Mycl-9E10 anti-
body. Proteins in the immune complexes were examined by
immunoblot analysis and subsequent autoradiography. In
contrast to immunoblots of protein extracts, with immuno-
precipitated proteins, we detected only the fastest- and the
slowest-migrating species of STE7M (Fig. 4B, lane 1). This
may occur because the intermediate-mobility forms are of
too low abundance or may not be recognized in their native
form by the Mycl-9E10 antibody. Nonetheless, the autora-
diograph of the immunoblot shows that both forms of
STE7M are phosphoproteins (Fig. 4C, lane 1). The amount
of protein in the slower-mobility band was less than the
amount in the faster-mobility band (Fig. 4B, lane 1). By








FIG. 4. Differeht phosphorylation states of STE7. (A) Immuno-
blot of protein extracts (60 ,ug) as specified below. Extracts were
incubated without (-) or with (+) alkaline phosphatase in the
absence (-) or presence (+) of phosphatase inhibitors. Lanes: 1,
E929-6C-1 (A, no STE7); 2 through 4, E929-6C-1/pNC250 (+,
high-copy-number plasmid CYCl-STE7). Anti-STE7 polyclonal an-
tibodies were used for detection. (B) Immunoblot of proteins
present in immune complexes from in vivo 32P-labeled protein
extracts. Cultures of strain E929-6C-35/pNC267 (high-copy-number
plasmid CYCI-STE7M) were incubated without (-) or with (+)
a-factor (a-fr; 50 nM, 2 h). Mycl-9E10 antibody was used both for
immunoprecipitation and immunoblot analysis. (C) Autoradiograph
showing 32P-labeled proteins on the filter in panel B. The arrow at
the right shows the position of hyperphosphorylated STE7. (D)
Analysis of phosphoamino acids present in hyperphosphorylated
STE7. STE7 was immunoprecipitated from TCA-SDS extracts of
pheromone-induced cultures of E929-6C-35/pNC267. The migration
of phosphorylated amino acid standards was visualized by reaction
with ninhydrin (left panel). 32P-labeled amino acids were visualized
by autoradiography days (right panel). 1.D, first dimension; 2.D,
second dimension.
slower-migrating species was much greater than that for the
faster-migrating form (Fig. 4C, lane 1). We obtained the
same results with use of the anti-STE7 serum to detect the
overproduced STE7 protein (data not shown). The stronger
signal confirms that the slow-electrophoretic-mobility form
of STE7 is more highly phosphorylated than the fast form.
The finding that STE7 is a phosphoprotein suggested that
transmission of the pheromone-induced signal might involve
an alteration in its phosphorylation state. To test this possi-
bility, we compared immunoprecipitated STE7 from unin-
duced and pheromone-induced cultures that were labeled
with 32p;. Under pheromone-induced conditions, the relative
amount of the slowest-migrating form of STE7 was much
greater than that found under uninduced conditions (Fig. 4B,
lanes 1 and 2). Again, the autoradiograph showed that the
slowest-migrating STE7M was more highly phosphorylated
than the fastest-migrating form (Fig. 4B, lane 2). Even after
only 5 min of pheromone induction, we still observed an
increase in the relative amount of hyperphosphorylated
STE7 (data not shown). We also found that pheromone
caused an increase in the relative amount of hyperphosphor-
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ylated STE7 even in the presence of the protein synthesis
inhibitor cycloheximide (data not shown). Therefore, new
synthesis of signal pathway components is not required. This
timing and independence from protein synthesis are consis-
tent with what has been established for pheromone-induced
signal transduction leading to transcriptional activation (25).
Therefore, STE7 hyperphosphorylation can be taken as an
indicator of post-G-protein signal activity.
Phosphoamino acid analysis of the in vivo-labeled STE7
protein was done to learn what groups become modified. The
hyperphosphorylated STE7 contained phosphoserine and
phosphothreonine but no phosphotyrosine (Fig. 4C). Using a
PhosphorImager to quantify signals, we found that phospho-
serine was six times more prevalent than phosphothreonine.
If the phosphoprotein form that we analyzed is homoge-
neously modified, as might be the case because of the
electrophoretic mobility shift, this result suggests that the
hyperphosphorylated form is multiply phosphorylated. Be-
cause the 2P signal associated with the fast-mobility STE7
phosphoprotein is very weak, we were unable to recover
sufficient counts to perform phosphoamino acid analysis on
this species.
The experiment described above showed that the ratio of
hyperphosphorylated STE7 to the less phosphorylated form
increased upon pheromone treatment. The results did not
establish whether there is depletion of the less phosphory-
lated form or whether there is conversion of it to the
hyperphosphorylated form. To distinguish between these
possibilities, we quantified the amounts of 35S-labeled STE7
in the slow- and fast-mobility forms before and after phero-
mone treatment. To examine only preexisting [35SJSTE7,
further protein synthesis was inhibited with cycloheximide
before pheromone induction. After immunoprecipitation,
proteins were fractionated by SDS-PAGE and visualized by
autoradiography of the dried gel (Fig. 5B). The sum of
counts in the STE7 fast- and slow-mobility bands was the
same for the two immunoprecipitation reactions (Fig. 5A).
This result shows that the same total amount of STE7 was
recovered in each reaction. In the absence of pheromone
induction, 36% of STE7 is in the hyperphosphorylated form.
By contrast, after pheromone treatment, 69% of the total
STE7 is in the hyperphosphorylated form. These results
establish that pheromone induction causes the phosphoryla-
tion of a preexisting pool of STE7 leading to an increase in
hyperphosphorylated STE7.
STE7 hyperphosphorylation requires STE7 function. To
determine whether hyperphosphorylation of STE7 depends
on its own activity, we compared phosphoprotein forms of
STE7 and STE7-R220 from uninduced and pheromone-in-
duced cultures. Strains with either a complete deletion of
STE7 or with the normal STE7 were transformed with a
low-copy-number (pNC318-R220) or high-copy-number
(pNC267-R220) plasmid that overexpress the STE7M-R220
protein to different extents. For reference, these strains also
were transformed with the corresponding low- and high-
copy-number plasmids that overexpress the functional
STE7M protein (pNC318 and pNC267).
The STE7M-R 20 protein is not hyperphosphorylated in
the absence of a functional STE7 protein (Fig. 6, lanes 3 and
4). This experiment allows one to conclude only that a
STE7-dependent kinase is required for its hyperphosphory-
lation. To test whether phosphorylation is due to autocatal-
ysis, we examined STE7M-R220 phosphoprotein forms when
the protein was expressed in the presence of a functional
STE7. The results that we obtained in this experiment
depended on the extent of STE7 overproduction. In strains
A. B.
STE7M - + +
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FIG. 5. Quantitative analysis of STE7 phosphoprotein forms.
Cultures of yeast strain E929-6C-35 either without (- STE7M) or
with (+ STE7M) pNC267 were labeled with [35S]methionine, treated
with cycloheximide (20 ,g/ml), and then incubated either without
(-) or with (+) a-factor (50 nM). After isolation of STE7M-Mycl-
9E10 immune complexes with Staphylococcus aureus cells, less
than 5% of the detectable STE7M remained in the supernatants.
Proteins in the immune complexes were fractionated by SDS-
PAGE, and the resulting gel was dried for further analysis. (A) The
counts per minute (cpm) for the slow- and fast-mobility forms of
STE7M were determined by directly counting the corresponding
regions on the SDS-polyacrylamide gel. (B) Autoradiograph show-
ing the positions and signal intensities for the slow- and fast-mobility
forms of STE7M (arrows) after SDS-PAGE.
with the low-copy-number plasmid, hyperphosphorylated
STE7M-R220 accumulated to the same extent as found with
the functional STE7M (Fig. 6, low copy, lanes 5 to 8).
Furthermore, phosphoamino acid analyses showed that the
7n220dohyperphosphorylated STE7-R1% protein was modified on
serine and threonine in the same ratio as found for the
wild-type protein (data not shown). These results exclude
the possibility that hyperphosphorylation of STE7 is re-
stricted to an intramolecular autophosphorylation mecha-
nism. By contrast, very little hyperphosphorylated STE7-
R220 accumulated when it was expressed from the high-copy-
number plasmid (Fig. 6, high copy, lanes 7 and 8). Therefore,
when STE7-R220 is expressed in amounts that interfere with
pheromone response, the kinase responsible for its phos-
phorylation is inhibited. The responsible kinase could be
either STE7 expressed from the chromosomal locus or
another kinase whose activity is pheromone inducible and
STE7 dependent.
It should be noted that an intramolecular autophosphory-
lation mechanism has been favored by Cairns et al. (2) to
explain hyperphosphorylation of STE7. Since these authors
compared phosphorylation of wild-type and mutant STE7
proteins only when the proteins were highly overproduced,
their experiments do not support this proposal. As we have
shown, the loss of hyperphosphorylation in the STE7-R220
mutant under these conditions is not due to its loss of
catalytic activity but is due to its interference with a phero-
mone-dependent process.
STE7 hyperphosphorylation requires the presence of other
signal pathway components. We wished to identify the signal
transmission components that must be present to allow
hyperphosphorylation of STE7 in response to pheromone.
To do this, we compared STE7 phosphoprotein forms in-
duced by ot-factor in a series of isogenic strains that have a
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FIG. 6. Immunoblots comparing STE7 and STE7-R220 phospho-
protein forms. Strain E929-6C-35 with a complete deletion of STE7
(ste7A) or strain E929-6C-22 with the normal genomic copy (STE7)
overproduced the functional STE7M or the inactive STE7M-R220
protein. Extracts were prepared from cultures either in the absence
of pheromone induction (-) or in its presence (+; 50 nM a-factor, 2
h). Panels are labeled at the left to indicate whether extracts were
from strains expressing STE7 or STE7-R220 from the corresponding
low-copy-number (pNC318 or pNC318-R220) or high-copy-number
(pNC267 or pNC267-R220) plasmid. Anti-STE7 serum was used for
detection of STE7 proteins. Each lane contains 60 ,ug of protein for
detection with low-copy-number extracts and 20 pg of protein for
detection with high-copy-number extracts. Positions of the hyper-
phosphorylated (4) and the fastest-migrating (*) forms of STE7 are
indicated at the right.
deletion in one of the different known signal components
(Table 1). Because the FUS3 and KSS1 predicted kinases
have partially redundant functions in this pathway, we
included in our comparison a strain that had a deletion of
both genes (11). Each of these strains was transformed with
STE7 expressed from a low-copy-number plasmid (pNC279)
to avoid conditions of high overproduction. The STE7
phosphoprotein forms were visualized by immunoblot anal-
ysis of cell extracts as before.
Pheromone treatment did not increase the amount of
hyperphosphorylated STE7 in strains deficient in the G^
subunit (STE4), the STE5 protein, the STEll kinase, or both
the FUS3 and KSS1 predicted kinases (compare Fig. 7A and
B, lanes 2 to 5). By contrast, STE7 was predominantly in the
hyperphosphorylated form in extracts of the control strain
and those strains with a deletion of genes encoding the FUS3
kinase, the KSS1 kinase, the STE12 transcription factor, or
FAR1 (Fig. 7A and B, lanes 1 and 6 to 9). These results show
that STE7 hyperphosphorylation does not require the STE12
protein, which is a DNA-binding protein, or the FAR1
protein, which is a regulator of cyclin activity (3, 13). By
contrast, the G. subunit (STE4), the STE5 protein, the
STEll kinase, and one or the other of the KSS1 and FUS3
kinases must be present for the pheromone-induced hyper-
phosphorylation of STE7. We obtained the same results in
strains expressing kinase-negative versions of STEll or
FUS3 as in strains with deletions (data not shown). There-
fore, we infer that the dependence of STE7 hyperphosphor-
ylation on the noted kinases is not structural but catalytic.
This analysis suggests that these proteins could provide a
signal function that is either prior to or interdependent with
that of STE7.
It is notable that differences in the proportion of hyper-
phosphorylated STE7 were apparent even for uninduced
FIG. 7. Pathway functions required for STE7 hyperphosphory-
lation. (A) Immunoblot detecting STE7 from protein extracts (50 pg)
of cultures in the absence of pheromone (- a-factor). Extracts are
from strains that are isogenic to E929-6C-0/pNC279 (lane 1, +)
except for the deletion (A) or disruption (-) of the specified genes
(lanes 2 to 9). Anti-STE7 polyclonal antibodies were used for
detection of STE7. (B) The same as panelA except that extracts were
prepared from pheromone-induced cultures (+ a-factor; 2.5 ,uM, 2 h).
conditions. Compared with the control, the ratio of slow- to
fast-mobility STE7 was less with extracts from strains defi-
cient in the STE4 G. subunit, the STE5 protein, the STEll
kinase, or both the FUS3 and KSS1 predicted kinases (Fig.
7A, lanes 1 to 5). The most severe effect was for the extracts
of strains which lacked the protein kinases. These results are
not unexpected. In normal cells, the signal pathway is active
at a low level even under uninduced conditions. Therefore,
the absence of some components, such as STE4 and STE5,
could be expected to reduce the residual signal in addition to
blocking the pheromone-induced signal. Because kinases
may have some activity even in the absence of a signal,
eliminating the residual signal should be less dramatic than
eliminating the components directly involved in the modifi-
cation.
Interestingly, the strains with deletion of only the FUS3
kinase or the STE12 transcription factor showed a higher
proportion of hyperphosphorylated STE7 compared with the
control strain in the absence of pheromone (Fig. 7A, lanes 1,
6, and 8). The unexpectedly high proportion of hyperphos-
phorylated STE7 observed for these backgrounds reveals
that there is normally a negative control on residual signal
activity. Further, this negative control is dependent on the
function of the STE12 transcription factor and the FUS3
kinase. These latter results are similar to what was reported
for phosphorylation of the inactive FUS3-R42 kinase (15).
Functional relationship between the STE7 and FUS3 ki-
nases. The foregoing observations presented us with a para-
dox. Activation of FUS3 by phosphorylation requires an
activity provided by the STE7 kinase (15), yet STE7 hyper-
phosphorylation requires an activity provided by the FUS3
or KSS1 kinase. Since even a catalytically inactive form of
FUS3 (FUS3-R42) undergoes a STE7-dependent phosphory-
lation, these observations are difficult to explain by a model
in which STE7 hyperphosphorylation is a necessary condi-
tion for its activity (15). The results are more easily accom-
modated by a model in which STE7 hyperphosphorylation is
a consequence of pheromone-induced activation but not the
determining event. According to the latter model, the pher-
omone-induced signal would generate an active STE7 even
in the absence of the FUS3/KSS1 function.
An experiment to test this hypothesis was suggested by
observations from immune complex kinase assays with
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FIG. 8. Evidence that FUS3 phosphorylation ir
coprecipitation of a STE7-dependent kinase. (A) Phc
the inactive FUS3-R42 protein in immune complext
was immunoprecipitated with Mycl-9E10 antibod
K2314 (fus3A::LEU2 ksslA::URA3)IpGA1905 (T
(lane 1) and E929-6C-35 (ste7A)/pGA1905 (lane 2). F
assays were performed directly on protein A-Seph
immune complexes as described in Materials and
Outline of the strategy to test whether STE7 activil
strains that lack FUS3 and KSS1. See text. (C) Pho
FUS3-R42 in immune complexes from mixed sign
acceptor extracts. Initiator and pheromone-induced
extracts were prepared from either strain K2314 (STI
ksslA::URA3)/pNC318 (low-copy-number CYCI-S
strain K2314/pNC318-R220 (low-copy-number CYCi
(R220). Acceptor extracts were prepared from eith
6C-35 (ste7A)/pGA1905 (TPIJ-FUS3M-R42) (R42) or
35/pGA1944 (TPI1-FUS3M-R42A180F182) (RAF).
mixed as indicated, and phosphorylation assays wer
for panel A. A nonspecific phosphoprotein that bec
rylated in all reactions is indicated by an asterisk a
intensity of this nonspecific signal serves as an inte
comparison of FUS3 phosphorylation from lane
phosphoproteins have a slower mobility than does
phospho2rotein and are not detected in this assay. (D
FUS3-R 2 phosphorylation does not occur with se
and acceptor extracts. Extracts and assays were;
panel C. (E) Analysis of FUS3-R42 phosphoamino ac
immune complex assays from mixed extracts. TI
phosphorylated amino acid standards was visualiz
with ninhydrin (upper panel). 32P-labeled amino aci
ized with a PhosphorImager print (lower panel). S,
T, phosphothreonine; Y, phosphotyrosine.
lates the catalytically inactive FUS3-R42 prol
lane 1). Only background amounts of phosphoi
when immune complexes are from extracts
functional STE7 protein (Fig. 8A, lane 2). Froi
we reasoned that FUS3 phosphorylation in i
plexes provides an indicator for the presence
STE7.
The following adaptation of the assay was m
ically determine whether STE7 activity is indu
that lack FUS3 and KSS1 (Fig. 8B). Extract,
Acceptor mone-induced cells that express STE7 and all other compo-
JS3M-R42 ] ste7i nents upstream of the FUS3 and KSS1 kinases serve as a
or signal initiator. Extracts from uninduced cells that lack
JS3M-RAF] ste7A STE7 (ste7A) but express the FUS3-R42 protein serve as a
signal acceptor. Because of this design, the only possible
source of an active STE7 is the initiator extract. If phero-
mone treatment induces STE7 function in the absence of
FUS3 and KSS1, we expect to observe STE7-dependent
ion phosphorylation of FUS3-R42 in the immune complexes
orylation upon addition of [_y-32P]ATP. Otherwise, phosphorylation ofFUS3-R42 should remain at background levels, suggesting
that STE7 hyperphosphorylation is a precondition for signal
E transmission.
Phosphorylation of FUS3-R42 occurred when the initiator
- ~ extract was from pheromone-induced ksslA fis3A cells that
/T express a functional STE7 protein (Fig. 8C, lane 2; Fig. 8D,
lane 4). Phosphorylation of FUS3-R42 was significantly less
when the initiator extract was from uninduced cells (Fig. 8C,
2' lane 1). There was no FUS3-specific phosphorylation in the
immune complexes formed with the separate initiator or
T acceptor extracts (Fig. 8D, lanes 1 to 3). To show that the
0
y phosphorylation in the immune complexes is still dependent
on a STE7 activity, we used initiator extracts from a STE7+
vitro requires fus3A ksslA strain that expresses the STE7-R220 protein
isphorylationrof from a low-copy-number plasmid (pNC318-R220). At this
es. FUS3M-R42 level of expression, the STE7-R220 protein does not interfere
ly from strains with signal transduction activity. Therefore, the only defec-
PI1-FUS3-R42) tive component in the initiator extract is the STE7-R220
'hosphorylation protein that will be present in the immune complex. Whether
iarose-adsorbed the STE7-R220 initiator extracts were prepared from phero-
I Methods. (B) mone-induced or uninduced cells, phosphorylation of the
sphoiylation Of FUS3-R42 protein in the acceptor extract remained at back-
al initiator and ground amounts (Fig. 8C, lanes 3 and 4; Fig. 8D, lane 5). The
initiator (+aF) implication of these results is that accumulation of hyper-
77fus33A::LEU2 phosphorylated STE7 is not necessary for this activity in
'TE7M) (wt) or immune complexes.
l-STE7MR220) The same FUS3-R42 sites were phosphorylated in this
strain E929-6C- assay as were observed for FUS3-R42 phosphorylation in
Extracts were vivo. First, phosphoamino acid analysis of the in vitro
re performed as 32P-phosphorylated FUS3-R42 protein showed that it was
iomes phospho- phosphorylated predominantly on threonine and tyrosine
A the right. The (Fig. 8E). Second, only background amounts of phosphory-
rnal control for lation resulted when the acceptor extract contained a mutant
to lane. STE7 FUS3 with substitutions at the in vivo phosphorylation sites
)) Evidence that (FUS3-R42A180F182) (Fig. 8C, lanes 5 and 6).
parate initiator These results are consistent with STE7 acting before
as specified for FUS3 in the signal transduction pathway. We know that
ids generated in STEll functions before the STE7 and FUS3 kinases because
,e migration of both are constitutively phosphorylated in strains with the
red by reaction STE11-1 allele that encodes a mutationally activated STEll
ids were visual- kinase, STE11-S279 (15, 42). Therefore, we expect that STE7
phosphoserine; function in signal transduction is required between that of
the STEll and FUS3 kinases. To test this assumption, we
compared FUS3 phosphorylation in STE11-1 STE7 and
STE11-1 ste7A strains by in vivo labeling. As shown previ-
tein (Fig. 8A, ously, FUS3 is 32p phosphorylated in the STE11-1 STE7
rylation result background (Fig. 9, lane 2) (15). In contrast, the amount of
s that lack a 32P-phosphorylated FUS3 is reduced to background
m this finding, amounts in the STE11-1 ste7A strain (Fig. 9, lane 1). These
mmune com- results confirm that STE7 is required to transmit the phero-
of an active mone-induced signal between the STEll and FUS3 kinases.
Because the same result was found for a STEJJ-1 strain that
iade to specif- expresses the inactive STE7-R220 protein, we conclude that
iced in strains the STE7 requirement is not structural but catalytic (data not












FIG. 9. Evidence that the STE11-S279-induced phosphorylation
of FUS3 requires the STE7 function. The STE11-S279 kinase (en-
coded by the STE11-1 allele) activates the signal pathway in the
absence of pheromone (42). FUS3 and CDC28 were immunoprecip-
itated from extracts of 32P-labeled yeast strains SY2172 (STEll-1
ste7-A&3::LEU2) transformed with pGA1840 (TPI1-FUS3) (lane 1)
and SY2172 cotransformed with pGA1840 and pSTE7.4 (lane 2). A
print obtained by PhosphorImager analysis is shown. The relative
intensities of the FUS3 signals are indicated.
DISCUSSION
Pheromone-induced signal transmission requires function
of several protein kinases at some point after G-protein
activation (7, 11, 12, 28, 36, 44). In this study, we investi-
gated one of these kinases, STE7, and its relationship to
other components of the signal pathway. We showed that
STE7 is present in multiple phosphoprotein forms in S.
cerevisiae yeast. Under conditions of pheromone induction,
the most highly phosphorylated form is the predominant
species. Therefore, we monitored STE7 hyperphosphoryla-
tion to learn what components of the signal transduction
pathway are necessary for the pheromone-induced modifi-
cation. Neither the STE12 transcription factor nor the FAR1
regulator of cyclin activity is required for STE7 hyperphos-
phorylation, showing that STE12 and FAR1 function in
pheromone response after or in parallel with STE7. In
contrast, the presence of the G,3 subunit (STE4), the STE5
protein, the STEll kinase, and either the KSS1 or FUS3
kinase is required for conversion of STE7 to the hyperphos-
phorylated form in response to pheromone (Fig. 10). The
implication is that each of these components must be acti-
vated by the pheromone-induced signal before modification
of STE7 can occur.
The correlation between hyperphosphorylation and the
pheromone-induced state suggests the simple hypothesis
that hyperphosphorylated STE7 is the active form of the
kinase. Since STE7 hyperphosphorylation requires an activ-
ity provided by STEll and either the FUS3 or KSS1 kinase,
this model predicts that all three of these kinases would
function prior to STE7 in the signal pathway. The model
deduced from the analysis of STE7 hyperphosphorylation,
however, is inconsistent with the finding that phosphoryla-
tion and activation of FUS3 and KSS1 require the presence
of STE7 (15). According to these results, STE7 activity is
required before the FUS3 and KSS1 step in signal transmis-
sion. We resolved this dilemma by showing that pheromone
induction stimulates STE7 activity even in the absence of
FUS3 and KSS1. Specifically, we showed an inactive FUS3-
R42 substitution protein is phosphorylated in immune com-
plexes from mixed extracts in which the only source of
active STE7 was a strain that lacked both FUS3 and KSS1.
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FIG. 10. Model for the pheromone-induced signal transmission
pathway. The diagram shows the postulated relationship of signal
transmission components that function after the pheromone-recep-
tor complex. Arrows indicate activation or stimulation. Lines with
bars indicate repression or inhibition. The dashed bar indicates that
it is unknown whether effects are stimulatory or inhibitory. PRE is
the pheromone response element that is a binding site for the STE12
transcription factor and is required for pheromone-inducible tran-
scription of target genes (stippled bar). A complex consisting of the
CDC28 kinase catalytic subunit and one or the other of the Gl-
specific cyclins (CLN) is required for progression of the cell cycle
from the G1 to S phase. The relationship between the G-protein
complex (Ga, GP, G,), STE5, and the STEll kinase is based on
considerations presented by Stevenson et al. (42). The relationships
between the STE11, STE7, and FUS3/KSS1 kinases are deduced
from results discussed in this report and reports by Stevenson et al.
(42) and Gartner et al. (15) (see also references 3, 11, and 28).
vates STE7 function before FUS3 or KSS1 activity is
required. Because there is no accumulation of hyperphos-
phorylated STE7 in the absence of FUS3 and KSS1, the
result also shows that accumulation of STE7 in this form is
not a precondition for signal transmission. Preliminary anal-
ysis of a STE7 N-terminal deletion further supports this
view. The mutant protein is functional and still requires
pheromone induction for activity, but it does not become
hyperphosphorylated (49).
These findings allow us to deduce a functional order for
the STE11, STE7, and FUS3/KSS1 kinases in the signal
pathway (Fig. 10). From the foregoing analysis, STE7 func-
tions before FUS3 and KSS1. We infer that STEll functions
prior to both the FUS3 and STE7 kinases because the
mutationally activated STE11-S279 protein causes both
FUS3 and STE7 to become phosphorylated in the absence of
pheromone (15, 42). The demonstration that STE7 activity is
required for the STE11-S279-stimulated phosphorylation of
FUS3 supports the proposal that STE7 function is required
between that of STEll and FUS3. Furthermore, these
biochemical analyses are completely consistent with the
predictions from the genetic analyses of the mutationally
activated forms of STEll (2, 42).
Our studies do not resolve the questions of what kinase is
directly responsible for STE7 hyperphosphorylation and
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what this modification does to STE7. The pheromone-
induced signal could stimulate a STEll-dependent phosphor-
ylation of STE7. This transient phosphoprotein could be a
more active protein kinase and rapidly progress to the
hyperphosphorylated form. However, intramolecular auto-
phosphorylation is not responsible for this conversion be-
cause the nonfunctional STE7-R220 protein still becomes
hyperphosphorylated in a wild-type STE7 genetic back-
ground. Modification of the STE7-R220 mutant could be by
an intermolecular autophosphorylation or by another kinase
whose activity is pheromone inducible and STE7 dependent.
Because of the deduced order of kinases in the pathway,
these data are consistent with the interesting possibility that
FUS3 and KSS1 modify STE7 directly after they have been
activated (Fig. 10). It is less clear what the consequences of
STE7 hyperphosphorylation may be. This modification
could provide a mechanism for feedback control by altering
enzyme-substrate interactions or attenuating STE7 activity.
The pheromone-induced accumulation of hyperphospho-
rylated STE7 also has been noted by Cairns et al. (2).
However, their study gives a different view of what may be
responsible for STE7 hyperphosphorylation and conse-
quently what significance it may have for signal transduc-
tion. A major discrepancy between their report and ours is
that according to Cairns et al., ste4, stell, and fus3 kssl
mutations do not affect STE7 hyperphosphorylation. There-
fore, they proposed that hyperphosphorylation of STE7
occurs by an autocatalytic mechanism or involves a novel
kinase (that must be independent of the pheromone-induced
signal).
We think that the differences between our study and that
of Cairns et al. (2) can be explained by differences in the
levels of STE7 expression. Cairns et al. used a potent GAL]
promoter to express STE7 so that all of their experiments
were done with highly overproduced protein. As we ex-
plained above, data in neither of our reports support argu-
ments in favor of intramolecular autophosphorylation. We
suspect instead that high levels of STE7 protein exaggerate
inappropriate phosphorylation events such as intermolecular
autophosphorylation or modification by kinases that are
distinct from but structurally related to the pheromone
pathway kinases. The latter possibility has credence because
another signal transduction pathway that uses kinases re-
lated to STEll (BCK1), STE7 (MKK1/MKK2), and FUS3/
KSS1 (MPK1) has been defined in S. cerevisiae (17a, 21a,
22). This interpretation would resolve the puzzle of how
STE7 phosphorylation is pheromone inducible yet under
certain conditions appears independent of pheromone path-
way components that, by weight of genetic analyses, func-
tion prior to STE7 (2, 42).
The order that we deduced for the pheromone response
pathway kinases makes STE7 a good candidate for the FUS3
and KSS1 activator (Fig. 10). Although we still do not have
evidence that STE7 catalyzes protein phosphorylation, in
principle it could activate FUS3 and KSS1 by directly
phosphorylating them. FUS3 and KSS1 are like other mem-
bers of the MAP kinase family in that they are activated by
phosphorylation on threonine and tyrosine residues located
within kinase subdomain VIII (33, 34). Recently MAP kinase
activators were identified biochemically and purified from
Xenopus cells and rabbit skeletal muscle (24, 30). These
activators are protein kinases with dual specificity for thre-
onine and tyrosine. Interestingly, a peptide sequence from
the Xenopus activator and the predicted protein from the
skeletal muscle activators show significant identities with the
STE7 protein sequence (9, 20, 29, 48).
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